OncoMed Pharmaceuticals SVP/CFO on Emerging Company Capital Formation Testimony

Type:

Video

William D. Waddill, Senior Vice President and Chief Financial Officer of OncoMed Pharmaceuticals, highlights the importance of capital formation to encourage investment in the biotechnology industry and spur job growth. Mr. Waddill provided testimony today on behalf of BIO at a Senate Committee on Banking, Housing, and Urban Affairs hearing.

September 12, 2011 2012 World Congress on Industrial Biotechnology and Bioprocessing	September 12, 2011 Podcast: Margaret Anderson, Executive Director of FasterCures	September 9, 2011 Contagion: How Would We Respond to a Pandemic?	September 9, 2011 Eva Jack, Chief Business Officer at Pulmatrix, on the Promise of Biotech
August 15, 2011 Dr. Steven Perrin, CEO, CSO and Vice Chairman, ALS Therapy Development Institute	August 11, 2011 When RARE is not so RARE!	June 30, 2011 2012 Flash Mob Event - 2011 BIO International Convention	June 30, 2011 Humanitarian Award Winner Dr. Paul Offit